Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Jan 12;123(5):759–768. doi: 10.1002/cncr.30421

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

(A) Overall survival for doxorubicin plus cyclophosphamide (AC)‐containing versus AC‐free (taxane) regimens using the Kaplan‐Meier method. (B) Overall survival of docetaxel (4 cycles of AC followed by 4 cycles of docetaxel [ACdT] plus docetaxel) versus paclitaxel (4 cycles of AC followed by 4 cycles of paclitaxel [ACpT] plus paclitaxel) regimens using the Kaplan‐Meier method. CI indicates confidence interval; DTx, 8 cycles of docetaxel without AC; PTx, 8 cycles of paclitaxel without AC.